SUNPHARMA — Sun Pharmaceutical Industries Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Sun Pharmaceutical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	44,813	94,084	110,879	137,521	151,189
Depreciation
Non-Cash Items	-1,688	1,931	-10,022	-14,550	-20,558
Unusual Items
Other Non-Cash Items
Changes in Working Capital	25,697	-66,050	-5,060	-8,004	-34,190
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	90,260	55,260	121,363	140,721	125,819
Capital Expenditures	-14,950	-20,856	-22,018	-21,286	-36,094
Purchase of Fixed Assets
Other Investing Cash Flow Items	-42,297	-58,581	15,116	-31,776	-77,347
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-57,247	-79,437	-6,902	-53,062	-113,441
Financing Cash Flow Items	-2,692	-1,001	-2,990	-31,270	-3,392
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-51,935	23,761	-67,102	-79,058	-25,126
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-17,648	1,155	46,619	9,831	-4,983